Other News To Note
Thursday, November 17, 2011
Aldagen Inc., of Durham, N.C., published a paper in the Journal of Stem Cell Research & Therapy describing the mechanisms by which its cell therapy products promoted formation of new blood vessels in ischemic tissues. The products induced expression of angiogenic genes encoding soluble growth factors, regulatory molecules and extracellular molecules that protect endothelial tubules from hypoxia-induced damage. Aldagen has clinical-stage programs targeting ischemia in the heart, brain and limbs.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.